(Photo Courtesy: www.www.adls.org.nz)
Mr Erik Kakes, executive VP, sales & marketing, Applikon Biotechnology said, "In Spinco Biotech we have found a partner organization that matches the quality of equipment and support that we are aiming to bring to the worldwide biopharmaceutical market. Our range of high end bioreactor systems complements the product range of Spinco and their excellent after sales organization guarantees our customers the optimal support."
The financial terms of this new agreement were not disclosed.
"This new agreement offers our customers innovative solutions and total quality satisfaction. We are very pleased to be working with the Applikon Biotechnology team and look forward to a long-term successful relationship," said Mr Arvind Thyagarajan, director, business development, Spinco Biotech.